Current Phase: Grant Review: Feb 8 - Feb. 22, 2020
Next Phase: Selection Meeting: March 2, 2020
ENTELLIGENCE Young Investigator Program
ENTELLIGENCE is a program for basic science, translational, and clinical research in the field of cardiopulmonary medicine.
The program provides opportunities for individual young investigators to promote quality medical care and enhance patients' lives by supporting research in pulmonary hypertension (PH) related to expanding our knowledge of the pathways involved in pulmonary vascular pathobiology. Click here for a short video about the program.
Sign Up For Reminder Alerts
The 2019-2020 grant submissions are being evaluated by the ENTELLIGENCE Steering Committee. All applicants will be notified by March 22, 2020
The ENTELLIGENCETM Young Investigator program is supported through an educational grant from Actelion Pharmaceuticals US, Inc. 
